Donald Trump receiving Covid-19 treatment yet to be peer-reviewed
President's doctor reveals treatment with experimental antibody cocktail REGN-COV2
Donald Trump is being treated with an experimental antibody drug that has shown promising initial early results but has yet to be peer-reviewed. According to statement from his doctor, the president has received a single eight-gram dose of an antibody cocktail called REGN-COV2 - a combination of two human neutralising antibodies against the virus.
The treatment was developed by Regeneron Pharmaceuticals, which previously developed a similar antibody drug against Ebola. He is also taking zinc, vitamin D, melatonin, aspirin and the heartburn drug famotidine - often sold in the US under the brand name Pepcid. Although the drug has not been shown to work against coronavirus, researchers are studying it as a possible treatment.
Continue reading...